Skip to main content

Table 3 Changes in mean of IIEF-5 score and EHS score after intracavernous injection of BM-MSC over follow up time points

From: Stem cell therapy in diabetic men with erectile dysfunction: a 24-month follow-up of safety and efficacy of two intracavernous autologous bone marrow derived mesenchymal stem cells injections, an open label phase 2 clinical trial

 

Baseline

Mean±SD

(n = 8)

1-month Mean±SD

(n = 8)

P-value

3-month Mean±SD

(n = 8)

P-value

6-month

Mean±SD

(n = 8)

P-value

12-month Mean±SD

(n = 8)

p-value

24-month Mean±SD

(n = 8)

P-value

IIEF-5

10.4±2.8

12.4±2.6

0.0156

15.8±3.4

0.0078

17.9±3

0.0003

15.1±4.3

0.0168

10.6±2.92

0.3506

EHS

1.5±0.5

2.1±0.6

0.0492

2.9±0.6

0.0012

3.5±0.5

< 0.0001

3±0.7

0.0025

1.5±0.53

0.5

  1. IIEF-5 International Index Erectile Function score, EHS Erection Hardness score, SD standard deviation
  2. Values are presented as mean ± standard deviation. The statistical analysis is performed via Wilcoxon signed rank test
Back to article page

Basic and Clinical Andrology

ISSN: 2051-4190